Harm de Vries
Co-founder and General Partner @ Innovation Industries
Amsterdam, The Netherlands
Harm de Vries is a seed investor at Innovation Industries in Amsterdam focused on Wearables and Health Care. Harm de Vries - Co-founder and General Partner @ Innovation Industries
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Harm de Vries invests in
Stages Harm de Vries invests in
Countries Harm de Vries invests in
Investment Focus
Industry
- Wearables 2 (40%)
- Health Care 2 (40%)
- Biotechnology 2 (40%)
- Medical Device 2 (40%)
- AgTech 1 (20%)
Stage
- Seed 2 (40%)
- Series B 1 (20%)
- Series C 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- The Netherlands 4 (80%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AIKON Health
|
AIKON Health offers a wearable device and data services for personalized heart failure management. | $1.4M / Seed / Jun 25, 2025 | |
IamFluidics
|
IamFluidics uses unique manufacturing procedures to create superior, long-lasting, and appealing goods based on high-quality microparticles. Using innovative and disruptive 'in-air microfluidics' production technology, the company produces monodisperse microbeads with regulated form, size, and composition. | $4M / Venture - Series Unknown / Sep 16, 2022 | |
AutoFill Technologies
|
AutoFill Technologies uses computer vision and AI to capture object data and detect damage to vehicles without the need for human interaction. Our patent-pending technology uses computer vision and AI to capture object data and detects damage to vehicles without the need for human interaction. We enable enterprises to minimize compliance risk,massively reduce labor costs and vastly enrich predictive vehicle inspection reporting. | $3M / Seed / Oct 29, 2021 | |
Solynta
|
Solynta is a breeding and biotechnology company based in Wageningen, the Netherlands – the home town of one of the leading agricultural research institutions in the world. The company develops and applies new breeding technologies to convert potatoes into a hybrid crop. Hybrid potato varieties with superior traits and performance are beinggenerated at a speed that is vastly greater than what can be achieved by traditional breeding. In addition, hybrid potatoes will allow sexual seed propagation, greatly enhancing the speed of product developments and providing tremendous logistical and phytosanitary advantages to the potato industry. | $24.7M / Series C / Aug 06, 2021 | |
Onera Health
|
Onera Health is a leader in transforming sleep medicine and remote monitoring. Their breakthrough diagnostic solutions and services are poised to help millions of people struggling with sleep-related ailments while also impacting other medical fields by monitoring various chronic conditions, ultimately improving the health and quality of life ofpatients worldwide. The company’s innovative solutions provide comprehensive sleep test data to physicians in a variety of clinical and non-clinical environments to optimize patient care and reduce healthcare costs. Onera has offices in the Netherlands and the US. | $12.5M / Series B / Jul 29, 2021 |
Co-Investors
About Innovation Industries
Innovation Industries is a venture capital firm that invests in hightech, medtech and agri-foodtech companies in The NetherlandsInnovation Industries maintains a hands-on management style, sharing its experience, knowledge and connections with the entrepreneurs. Portfolio companies are actively supported in order to strengthen the valueproposition, improve the time-to- market, identify and realize global strategic partnerships and avoid the typical start-up pitfalls. Innovation Industries sees itself as a partner of the entrepreneurs and the other parties involved; a creator of ventures, rather than merely a financial investor.Innovation Industries focuses primarily on start-ups but will also be able to invest into scale-ups. With this relatively broad spectrum of funding capabilities, emerging breakthroughs in research and technology can be sustained by sufficient venture capital to optimize their chances of success and ultimately provide returns to the Fund’s investors. Once these companies are established with seed funding, the Fund will be able to continue financing the advancement of these businesses and technologies.
Innovation Industries Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Chris Sonnenberg
General Partner
|
|||
|
Harm de Vries
Co-founder and General Partner
|
|||
Nard Sintenie
General Partner
|
|||
|
Tom Schwarz
Partner
|
|||
Tom van Vuren
Investment Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Harm de Vries invest in?
Harm de Vries invests primarily in Wearables, Health Care and Biotechnology startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Harm de Vries last invest?
The most recent investment recorded for Harm de Vries closed in Jun 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
